In The News

In Law360, Health Care Attorneys Examine State Drug Pricing Reforms

Practices: Health Care, Managed Care, Drug Pricing & Price Reporting, Health Care Finance & Restructuring, Administrative Litigation, Life Sciences

Capital Insights.

Drug pricing is at the forefront of U.S. health policy and a topic of interest at the federal and state level. In the second installment of a three-part series in Law360 on drug pricing reform, health care partner Deborah Kantar Gardner, counsel Peter Holman Jr. and associate Dustin Schaefer  review the status of key state drug pricing reforms, where some of the more immediate impacts of drug pricing are occurring.

The authors analyzed four common state initiatives: drug pricing transparency; pharmacy benefit manager controls; drug importation; and value-based arrangements.

Cookie Settings